DEUTSCHE BANK AG\ - NOVARTIS A G ownership

NOVARTIS A G's ticker is NVS and the CUSIP is 66987V109. A total of 870 filers reported holding NOVARTIS A G in Q1 2016. The put-call ratio across all filers is 0.75 and the average weighting 0.5%.

Quarter-by-quarter ownership
DEUTSCHE BANK AG\ ownership history of NOVARTIS A G
ValueSharesWeighting
Q3 2023$5,117,345
-0.6%
50,239
-1.5%
0.00%0.0%
Q2 2023$5,146,411
+842.7%
51,000
+759.5%
0.00%
Q1 2023$545,928
+0.8%
5,934
-0.6%
0.00%
Q4 2022$541,598
+18.5%
5,970
-0.7%
0.00%
Q3 2022$457,000
-9.9%
6,012
+0.3%
0.00%
Q2 2022$507,000
-3.6%
5,9970.0%0.00%
Q1 2022$526,000
-60.6%
5,997
-60.7%
0.00%
-100.0%
Q4 2021$1,335,000
-0.3%
15,253
-6.9%
0.00%0.0%
Q3 2021$1,339,000
-13.0%
16,379
-2.9%
0.00%0.0%
Q2 2021$1,539,000
-73.9%
16,875
-75.5%
0.00%
-66.7%
Q1 2021$5,889,000
-36.3%
68,901
-29.6%
0.00%
-50.0%
Q4 2020$9,241,000
+21.0%
97,865
+11.5%
0.01%
+20.0%
Q3 2020$7,635,000
+5.5%
87,793
+5.9%
0.01%
-16.7%
Q2 2020$7,238,000
+14.8%
82,865
+8.3%
0.01%0.0%
Q1 2020$6,307,000
-15.2%
76,482
-2.7%
0.01%
+20.0%
Q4 2019$7,437,000
+22.2%
78,565
+12.2%
0.01%
+25.0%
Q3 2019$6,084,000
+2.8%
70,050
+8.0%
0.00%
+33.3%
Q2 2019$5,919,000
+24.9%
64,854
+31.5%
0.00%0.0%
Q1 2019$4,740,000
-90.0%
49,325
-91.1%
0.00%
-91.2%
Q4 2018$47,466,000
+16.5%
553,174
+16.9%
0.03%
+183.3%
Q3 2018$40,753,000
-57.8%
473,020
-63.0%
0.01%
-55.6%
Q2 2018$96,588,000
+1898.5%
1,278,669
+2038.1%
0.03%
+1250.0%
Q1 2018$4,833,000
+167.0%
59,803
+177.2%
0.00%
+100.0%
Q4 2017$1,810,000
-40.1%
21,575
-38.7%
0.00%
-50.0%
Q3 2017$3,023,000
+5.6%
35,223
+2.6%
0.00%0.0%
Q2 2017$2,863,000
-88.8%
34,332
-90.0%
0.00%
-89.5%
Q1 2017$25,549,000
+1310.8%
344,035
+1282.9%
0.02%
+1800.0%
Q4 2016$1,811,000
-81.2%
24,877
-79.6%
0.00%
-85.7%
Q3 2016$9,642,000
-12.5%
122,156
-8.6%
0.01%
-12.5%
Q2 2016$11,024,000
-47.4%
133,645
-53.8%
0.01%
-50.0%
Q1 2016$20,952,000
-43.8%
289,264
-33.2%
0.02%
-38.5%
Q4 2015$37,273,000
+62.3%
433,244
+73.4%
0.03%
+44.4%
Q3 2015$22,969,000
+22.9%
249,910
+31.4%
0.02%
+50.0%
Q2 2015$18,696,000
-12.7%
190,144
-12.4%
0.01%
-7.7%
Q1 2015$21,410,000
+59.1%
217,150
+49.5%
0.01%
+62.5%
Q4 2014$13,454,000
-3.7%
145,244
-2.2%
0.01%
-11.1%
Q3 2014$13,975,000
+0.7%
148,489
-3.1%
0.01%0.0%
Q2 2014$13,875,000
+158.8%
153,295
+142.9%
0.01%
+125.0%
Q1 2014$5,362,000
-35.2%
63,102
-38.7%
0.00%
-33.3%
Q4 2013$8,272,000
-13.0%
102,947
-17.0%
0.01%
-14.3%
Q3 2013$9,510,000124,0160.01%
Other shareholders
NOVARTIS A G shareholders Q1 2016
NameSharesValueWeighting ↓
GODSEY & GIBB, INC 184,900$15,121,0006.74%
Martin Investment Management, LLC 289,924$23,710,0005.98%
Camber Capital Management LP 2,000,000$163,560,0005.04%
MANAGED ASSET PORTFOLIOS, LLC 381,778$31,222,0004.76%
PROFESSIONAL ADVISORY SERVICES INC 267,779$21,899,0003.22%
SCHARF INVESTMENTS, LLC 1,244,711$101,794,0003.21%
GARLAND CAPITAL MANAGEMENT INC 50,755$4,151,0002.97%
First Fiduciary Investment Counsel, Inc. 167,378$13,688,0002.67%
WILKINS INVESTMENT COUNSEL INC 130,590$10,680,0002.61%
Lowell Blake & Associates Inc. 66,309$5,423,0002.52%
View complete list of NOVARTIS A G shareholders